Literature DB >> 10802774

Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology.

G S Gronseth1, E J Ashman.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10802774     DOI： 10.1212/wnl.54.9.1720

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  16 in total

1.  The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis.

Authors:  Adrian W Davidson; Richard F Scott; Keith W Mitchell
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

Review 2.  The clinical role of evoked potentials.

Authors:  P Walsh; N Kane; S Butler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

3.  Horner Syndrome in a Case of Neuromyelitis Optica.

Authors:  Lilia Lovera; Walter M Jay; Jose Biller
Journal:  Neuroophthalmology       Date:  2014-02-07

4.  Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.

Authors:  Audrey R Frohman; Zane Schnurman; Amy Conger; Darrel Conger; Shin Beh; Benjamin Greenberg; Erich Sutter; Peter A Calabresi; Laura J Balcer; Teresa C Frohman; Elliot M Frohman
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

5.  Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.

Authors:  Niphon Chirapapaisan; Sawarin Laotaweerungsawat; Wanicha Chuenkongkaew; Patthanee Samsen; Ngamkae Ruangvaravate; Atiporn Thuangtong; Nacha Chanvarapha
Journal:  Doc Ophthalmol       Date:  2014-10-21       Impact factor: 2.379

6.  Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability.

Authors:  Daniel S Reich; Seth A Smith; Eliza M Gordon-Lipkin; Arzu Ozturk; Brian S Caffo; Laura J Balcer; Peter A Calabresi
Journal:  Arch Neurol       Date:  2009-08

Review 7.  Pediatric multiple sclerosis.

Authors:  Brenda L Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

8.  Disease-modifying Therapies for Multiple Sclerosis.

Authors:  John R. Corboy; Douglas S. Goodin; Elliot M. Frohman
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

9.  Pattern visual evoked potentials in Japanese patients with multiple sclerosis without history of visual pathway involvement.

Authors:  Atsushi Mizota; Noriko Asaumi; Michihiko Takasoh; Emiko Adachi-Usami
Journal:  Doc Ophthalmol       Date:  2007-06-05       Impact factor: 2.379

Review 10.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.